1. Introduction {#sec0001}
===============

*Yellow* ( *y*) was one of the first *Drosophila* mutants discovered \[[@bib1]\] and encodes a multifunctional protein with close similarity to the major royal jelly protein of honeybees. According to the *Drosophila* gene expression database, [FlyAtlas.org](http://FlyAtlas.org){#interref1} \[[@bib2]\], *y* is specifically expressed only in larval salivary glands, suggesting a secretory or digestive function. Royal jelly is secreted from analogous glands in the heads of honeybee workers, suggesting a conserved role for *y*. It has been proposed that in the honeybee *y* proteins may regulate development epigenetically by promoting DNA methylation \[[@bib3]\]. *Y* is also extensively expressed in the pupal cuticle, where it plays a major role in melanisation \[[@bib4]\]; and expression in the CNS is required for normal male reproductive behaviour \[[@bib5; @bib6; @bib7]\]. So *y* appears to play multiple roles, although its exact biochemical modes of action are still unknown.

It has been proposed that Yellow is a structural protein and that it is involved in forming cross-links with the dopamine derivative indole-5,6-quinone during melanisation \[[@bib5]\]. Another theory is that it acts downstream of dihydroxyphenylalanine (DOPA) in the formation of melanin; there is some sequence homology between the *y* protein and dopachrome conversion enzyme (DCE) \[[@bib8]\].

In previous papers we have looked at the effects of a known genetic lesion *rosy* on the global metabolite profile in *Drosophila* and found effects on metabolites remote from those directly affected by the lesion \[[@bib9]\] and also attempted to explain an unknown genetic lesion \[[@bib10]\]. We report here the application of metabolomics in order to elucidate the effects of the *y* gene.

2. Materials and methods {#sec0002}
========================

2.1. Chemicals and solvents {#sec0003}
---------------------------

HPLC grade acetonitrile, formic and water were obtained from Fisher Scientific, UK. All other chemicals were from Sigma--Aldrich, UK.

2.2. Fly larvae {#sec0004}
---------------

Laboratory grown wild-type Oregon R strain of *Drosophila melanogaster* was used as the control for the *y1* amorphic mutant (Bloomington Stock Centre, Indiana, \#169). Larvae were raised on standard medium on a 12:12 h L:D cycle, at 23 °C, and at 55% relative humidity. For metabolomic analysis, feeding third-instar larvae (before they stop feeding and climb away from their food) were selected. Ice cold methanol/chloroform/water (3:1:1, 250 μl) was used in the sample quenching and extraction method. Ten larvae from both genders were collected from the food for each biological replicate. First the larvae were rinsed in phosphate buffer saline (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na~2~HPO~4~ and 1.47 mM KH~2~PO~4~; adjusted to a final pH of 7.4), blotted dry, then homogenised in the solvent mixture, followed by 10 s of sonication. The homogenate was then centrifuged for 10 min at 4 °C. The supernatant was collected and stored at −80 °C until analysis. A total of four biological replicates containing 10 mixed male and female larvae was collected for each strain at each time point.

2.3. DNA/RNA hydrolysis {#sec0005}
-----------------------

DNA/RNA was extracted from 100 larvae for each biological replicate using the phenol--chloroform extraction method \[[@bib11]\]. A total of four biological replicates were prepared for both Oregon R and the *y* mutant. Briefly, the DNA extraction procedure was as follows: whole larvae were ground in a 1.5 ml microcentrifuge tube using a hand pestle and subsequently sonicated briefly using a Microson Ultrasonic cell disruptor (Misonix Inc, USA) in 400 μl buffer A (100 mM Tris--HCl (pH 7.5), 100 mM EDTA, 100 mM NaCl, 0.5% SDS). After incubation at 65 °C for 30 min, 800 μl of LiCl/KAc mixture (1 part 5 M KAc:2.5 parts 6 M LiCl) was added. The samples were spun for 15 min at room temperature (RT) at maximum speed in a table-top microcentrifuge. Floating curd was removed using a pipette tip and 1 ml of supernatant was taken into a new tube. Then, 600 μl of isopropanol was added and the sample was mixed using a pipette. Another round of centrifugation was performed at RT for 15 min. The supernatant was discarded and the pellet was washed with 70% ethanol and dried for 15 min at RT. Dried pellet was re-suspended in 100 μl of nuclease-free water. DNA/RNA was quantified using a NanoVue plus spectrophotometer (GE Life Sciences, UK).

For DNA/RNA hydrolysis, a method was adapted from Kriaucionis et al. \[[@bib12]\]. Briefly, 100 μg of DNA/RNA were incubated in the hydrolysis solution (100 mM NaCl, 20 mM MgCl~2~, 20 mM Tris pH 7.9, 1 U/μl Benzonase^™^ endonuclease, 600 mU/ml phosphodiesterase I, 80 U/ml alkaline phosphatase, 36 μg/ml EHNA-hydrochloride, 2.7 mM desferoxamine). Hydrolysed DNA/RNA was filtered using an Amicon microcon 10 kDa cut-off centrifugal filter unit (Millipore UK Ltd.). The hydrolysate was used for LC--MS analysis after diluting (1:4) with acetonitrile.

2.4. Nuclear protein isolation {#sec0006}
------------------------------

For histone analysis, the nuclear protein fraction was extracted using NE-PER nuclear extraction reagent kit (Thermo Scientific, UK). Briefly, 50 larvae were washed in phosphate buffer saline (PBS) 3 times. Using a pipette, all the residual PBS was removed and the larvae were homogenized at 4 °C in ice-cold CER I buffer (including 1:100 protease inhibitor cocktail from Sigma--Aldrich, UK). The rest of the extraction was performed according to the manufacturer protocol. Finally the nuclear fraction was collected and protein quantity was measured using a Bradford calorimetric protein assay kit (BIO-RAD, UK). A total of 80 μg of nuclear protein was used for the hydrolysis as follows. The protein was mixed with 160 μl of 6M HCl in a vial. The vial was sealed and heated in an oven at 145 °C for 4 h. The mixture was cooled and 160 μl of 3 M sodium bicarbonate was added. Then 0.4 ml of acetonitrile was added to a protein crash plate (Biotage Ltd, Sweden) followed by 0.2 ml of the acid hydrolysate. Salts were allowed to precipitate for 10 min and then the sample was filtered. The filtrate was used for LC--MS analysis.

2.5. LC--MS method {#sec0007}
------------------

LC--MS data were acquired using an LTQ Orbitrap instrument (Thermo Scientific, UK) set at 30,000 resolution. Sample analysis was carried out under both positive and negative ion modes. The mass scanning range was *m*/*z* 50--1200, the capillary temperature was 200 °C and the sheath and auxiliary gas flow rates were 30 and 10 arbitrary units respectively. The LC--MS system (controlled by Xcalibur version 2.0, Thermo) was run in binary gradient mode. Solvent A was 0.1% v/v formic acid in HPLC grade water and solvent B was 0.1% v/v formic acid in acetonitrile. Analysis was carried out on a ZICHILIC column (150 × 4.6 mm, 5 μm particle size, HiChrom Ltd., UK) fitted with a guard column. A flow rate of 300 μl/min was used and the injection volume was 10 μl, the gradient used was as follows: 90% B at (0 min) -- 50% B at (16 min) -- 20% B at (18 min) -- 20% B at (28 min) -- 90% B at (36 min). Samples were kept in a vial tray which was set at a constant temperature of 3 °C. The injection volume was 25 μl.

The instrument was calibrated according to the manufacturer\'s instructions just before commencing the experiment, and was internally calibrated by lock masses (positive ion mode *m*/*z* 83.06037 and *m*/*z* 195.08625, due to acetonitrile dimer and caffeine respectively; and negative ion mode 91.00368 due to formic acid dimer). Runs were carried out in negative ion mode using the conditions above after tuning in the negative ion mode and the assigning appropriate lock mass. Runs were also carried out on an Orbitrap Exactive instrument fitted with a HCD cell using the same mass spectrometry parameters and chromatographic conditions with a HCD cell energy of 20 eV.

2.6. Data processing {#sec0008}
--------------------

Data files were processed using Sieve 1.3 (Thermo, UK). The parameters used in Sieve were: time range 4--30 min, mass range 75--700 amu, frame width 0.02 amu and Rt width 2.5 min. The output from Sieve was transferred into Sieve Extractor, an Excel spreadsheet and an in-house macro written in Visual Basic, and used to search against a mass list of 35,000 compounds taken from the KEGG, Metlin, Human Metabolome and Lipid Maps databases. A 3 ppm window was set for assignment of elemental composition and often there was only one chemically sensible elemental composition within this window. Matching against the database confirmed this where only one hit was returned or if more than one hit was returned then the additional hits were isomers. Sieve software measures *P*-values using a two-tailed Student\'s *t*-test. We have found good agreement for selected compounds between manually calculated values and the values returned by the software. Profiling was based on for samples of larvae taken at three time points during two months ( *n* = 4 at each sampling point). Repeat sampling gives more confidence in the stability of differences over time. It is not possible to combine results from separate sampling points because of variations in instrument sensitivity and chromatography; relatively small variations in chromatographic retention time make peak alignment difficult.

3. Results and discussion {#sec0009}
=========================

[Table 1](#tbl0001){ref-type="table"} summarises some putatively identified unusual metabolites present in the larvae and also metabolites where there is a marked variation between *y* and OR. Novel metabolites were individually curated, requiring a mass accuracy within 1.5 ppm of the proposed structure, and with no sensible elemental composition within 3 ppm of the assigned elemental composition based on the elements C, N, H, O, P and S. All the metabolites listed in [Table 1](#tbl0001){ref-type="table"} were also checked manually to confirm that they were not isotope peaks, adducts, fragments or dimers of more intense ions. [Table S1 (supplementary)](#sec0026){ref-type="sec"} shows the MS^2^ data for some the more unusual metabolites which helps to confirm their structures.

*y* is a visible mutant of melanisation, and appears to lack homology to known enzymes in the tyrosinase/dopa pathways, but instead supports the activity of dopachrome-converting enzymes Yellow-f and Yellow-f2 \[[@bib8]\]. As might be expected there is thus a marked effect of the absence of *y* protein on metabolites in the pathway of eumelanin biosynthesis ([Fig. 1](#fig0001){ref-type="fig"}) with phenylalanine, tyrosine, DOPA and dihydroxyindole (DHI) consistently accumulating in all three batches of *y* larvae analysed. A widespread theory of the action of *y* is that it governs dopachrome conversion. However, the presence of DHI in *y*, which is an immediate precursor of eumelanin, indicates that it is not simply lack of a precursor which blocks eumelanin biosynthesis. The only enzymatic step between DHI and eumelanin is catalysed by tyrosinase which is used twice in the pathway leading to DHI. A clue to the fate of DHI not used in melanin biosynthesis is given by the presence of relatively abundant peaks which correspond to the glutathione adducts of DHI ([Fig. 2](#fig0002){ref-type="fig"}); the multiple peaks are due to reaction at more than one position in the ring system. The levels of DHI-GSH do not differ between *y* and OR. Apart from the eumelanin biosynthesis pathway there are number of other metabolic pathways that are strikingly affected in *y*.

The most metabolites within a single pathway that are affected by the mutation are related to lysine metabolism ([Fig. 3](#fig0003){ref-type="fig"}). A major metabolite of lysine in the larvae is fructosyl lysine which has only been reported as a non-enzymatic glycation product deriving from the reaction between lysine residues within proteins and glucose \[[@bib13]\]. Lysine is consistently elevated in *y* and the lysine metabolite saccharopine is elevated between 5 and 10 times compared to OR. The elevated levels of saccharopine are interesting in view of the recent finding that the ketoglutarate reductase (dLKR)/saccharopine dehydrogenase (SDH), the enzyme responsible for saccharopine formation, has been found to suppress ecdysone-mediated cell death \[[@bib14]\]. dLKR/SDH suppresses the activity of ecdysone by binding to histones H3 and H4 thus inhibiting arginine methylation within the histone tails. In *y,* lysine acetate levels are elevated \>x3 and, when compared with OR, and methyl-, dimethyl- and trimethyllysine are two to three times lower than in OR. Both acetyl-lysine and methylated lysines are derived from turnover of histones and provide two strategies controlling chromatin remodelling and thus gene transcription. Acetylation of lysine removes the electrostatic interaction between the lysine residues in histone and the phosphate backbone of DNA allowing access of transcriptional enzymes \[[@bib15]\]. *y* larvae also contain elevated levels of aminoadipate which is the next step in the lysine degradation pathway. Tryptophan metabolism via the kynurenine pathway is also affected with hydroxykynurenine levels being lower in *y* and levels of the downstream metabolites in this pathway kynurenic acid and xanthurenic acid being elevated. Both kynurenic and xanthurenic acids are produced by the enzyme [l]{.smallcaps}-kynurenine:2-oxoglutarate aminotransferase (KOA). The gene coding for this enzyme is orthologous with 2-aminoadipate transaminase which is responsible for the formation of oxoadipate from aminoadipate in the lysine degradation pathway. Thus increased levels of kynurenic acid and xanthurenic acid may be linked to the increase in lysine degradation products.

Several metabolic changes observed in *y* larvae were consistent with variation in histone modification. Histone proteins are steadily turned over \[[@bib16]\] and might be expected to contribute modified methyllysines and dimethylarginine to the metabolome. In addition, methionine and *S*-adenosyl methionine accumulate in *y* as if they were being underutilised. This suggests some differences in the regulation of methylation between OR and *y*. In order to determine whether or not *y* is directly involved in controlling the level of methylation of histone proteins, histones were isolated from OR and *y* larvae and subjected to a simple acid hydrolysis. Although the isolated proteins were rich in methylated lysine residues, particularly trimethyl lysine, there were no significant differences in the degree of methylation of histones from *y* and OR. In addition to methylated lysines there was an abundance of dimethylarginine present in the hydrolysate from the histones but there was no significant difference between dimethyl arginine in hydrolysates from *y* and OR histones. [Table S2 (supplementary)](#sec0026){ref-type="sec"} summarises the data obtained for methyllysines and arginine in OR and *y* normalised to the mean areas for the peaks for lysine or arginine in the hydrolysate.

Since it has been proposed that royal jelly proteins may be involved in epigenetic modification of DNA via methylation \[[@bib17]\] and it was decided to examine DNA isolated from OR and *y*. DNA/RNA was isolated from OR and *y* larvae and enzymatically digested to yield free DNA/RNA bases and then analysed by LCMS. All of the bases detected were derived from RNA and contained ribose rather than deoxyribose and no modified DNA bases were detected. It was possible to see methylated bases to a level of *ca* 0.1% of the non-methylated bases ([Fig. S1 supplementary](#sec0026){ref-type="sec"}), there was no significant difference in the levels of methylated RNA bases between OR and *y*. [Table S3 (supplementary)](#sec0026){ref-type="sec"} summarises the data obtained for DNA and RNA bases isolated by hydrolysis.

[Table 1](#tbl0001){ref-type="table"} also shows a number of changes in the levels of chitin precursors and the current study supports the idea that *y* behaves like a regulatory hormone or cofactor affecting a variety of metabolic pathways. Effects on chitin biosynthesis point to *y* possibly mediating its effects through regulation of ecdysone activity which has been found to regulate genes involved in chitin biosynthesis \[[@bib18]\]. It may be that the regulation of chitin biosynthesis is most significant with regard to the function of *y* since formation of the correct chitin structure may be necessary for proper functioning of melanin production.

Supplementary Material {#sec0026}
======================

Supplementary material associated with this article can be found, in the online version, at [doi:10.1016/j.fob.2012.07.007](http://dx.doi.org/10.1016/j.fob.2012.07.007){#interref2}.

Appendix. Supplementary material {#sec0027}
================================

Table S1MS^2^ data at 35 V for some of the more unusual metabolites extracted from the larvae.

We thank Scottish Universities Life Sciences Alliance for funding for mass spectrometry equipment. Work in the Dow laboratory is generously supported by the UK Biotechnology and Biological Sciences Research Council.

![Impact of *y* mutation on eumelanin biosynthesis with known *Drosophila* enzymes indicated, and fold changes for metabolites for *y* versus OR (from [Table 1](#tbl0001){ref-type="table"}) shown in arrows.](gr1){#fig0001}

![Extracted ion trace showing the putatively identified GSH conjugates of DHI.](gr2){#fig0002}

![Impact of *y* mutation on lysine catabolism with known *Drosophila* enzymes indicated, and fold changes for metabolites for *y* versus OR (from [Table 1](#tbl0001){ref-type="table"}) shown in arrows. Note that there are no enzymes present in drosophila capable of synthesizing lysine; as in other higher animals, lysine is an essential amino acid.](gr3){#fig0003}

###### 

List of unusual metabolites and metabolites displaying significant differences (*n* = 4 at each sampling point) between y and OR larvae. Four extracts from 10 *y* and 10 OR mixed male and female larvae were prepared on 3 occasions over a two month time period. "Ratio" is of *y*: OR peak area.

  Compounds                       MH^+^/M^−^   Rt     Replicate 1   Replicate 2   Replicate 3                      
  ------------------------------- ------------ ------ ------------- ------------- ------------- ---------- ------- -----------
  Melanin biosynthesis                                                                                             
  *Dihydroxyindole*               150.0545     8.0    3.30          1.80E−02      4.15          1.90E−02   2.27    5.50E−02
  Phenylalanine                   166.0864     12.4   2.21          7.10E−06      2.18          3.90E−03   1.99    3.10E−04
  Tyrosine                        182.081      14.9   1.73          5.90E−03      2.12          9.30E−02   3.32    1.70E−04
  Dopamine acetate                196.097      7.5    0.52          1.70E−03      2.30          1.80E−01   0.523   4.00E−01
  DOPA                            198.0761     17.3   2.67          3.00E−02      3.29          1.30E−03   3.229   5.20E−03
  Glycyl-dopa                     255.0978     17.1   1.34          2.10E−01      1.96          1.40E−01   1.98    5.80E−02
  Dihydroxy indole GSH            455.1231     17.2   0.90          8.20E−01      ND                       0.64    3.30E−01
  *Lysine metabolism*                                                                                              
  Lysine                          147.1129     23.4   2.23          1.20E−02      2.07          3.70E−02   1.62    3.90E−02
  Methyllysine                    161.1287     23.0   0.62          7.70E−04      0.72          4.30E−02   0.83    2.70E−01
  2-Aminoadipate                  162.0763     16.1   2.00          2.20E−02      2.28          2.90E−02   1.38    1.30E−01
  Carnitine                       162.1127     15.4   0.60          2.30E−08      0.60          6.90E−04   0.81    1.50E−02
  Dimethyl lysine                 175.1442     23.1   0.41          3.00E−05      0.39          1.80E−04   0.56    2.40E−02
  Lysine acetate                  189.1236     16.4   6.19          4.70E−03      4.50          5.00E−03   3.16    4.70E−05
  Trimethyl lysine                189.1599     23.8   0.36          3.30E−03      0.45          2.00E−03   0.61    1.30E−01
  Diaminopimelate                 191.1028     16.6   0.66          1.30E−02      0.51          7.90E−03   0.77    2.80E−03
  Aspartyl lysine                 262.1397     21.5   0.01          5.80E−05      0.05          1.20E−01   0.064   7.50E−03
  Saccharopine                    277.1395     20.8   8.20          1.80E−02      9.50          5.80E−03   5.093   3.70E−02
  Fructosyl lysine                309.1658     23.8   0.47          3.70E−03      0.78          3.30E−02   0.87    5.00E−01
  *Chitin biosynthesis*                                                                                            
  *N*-acetylglycosamine           222.0975     13.5   0.10          3.20E−02      0.50          5.80E−01   0.198   2.00E−01
  *N*-acetylglycosamine isomer    222.0975     15.0   0.06          3.00E−02      0.54          6.7 E−01   0.045   2.10E−01
  Glycosamine phosphate isomer    260.0532     19.9   1.55          4.20E−03      0.95          6.30E−01   0.374   2.30E−01
  Glycosamine phosphate isomer    260.0532     22.2   0.14          6.50E−04      ND            ND         0.024   4.70E−03
  Neuraminic acid                 268.1027     20.0   1.71          5.70E−04      3.44          4.40E−04   2.003   2.00E−03
  Glycosamine acetate phosphate   302.0638     19.8   0.35          1.20E−02      0.66          4.60E−02   0.58    2.30E−03
  Cytidine monophosphate          324.0594     20.4   2.40          3.20E−02      7.77          9.80E−03   3.51    4.20E−02
  UDP Glc NAc                     608.0886     25.8   1.16          1.70E−01      2.01          4.50E−02   1.812   6.50E−03
  *Tryptophan metabolism*                                                                                          
  Kynurenic acid                  190.05       8.9    2.52          4.80E−03      2.29          4.10E−03   3.289   2.00E−04
  Xanthurenic acid                206.0449     10.6   2.31          8.90E−03      2.68          5.90E−02   7.904   2.90E−03
  Hydroxytryptophan               221.0923     12.8   0.35          4.50E−02      0.12          4.60E−03   0.26    6.30E−02
  Hydroxykynurenine               225.087      14.2   0.40          3.70E−06      0.35          8.70E−04   0.43    1.10E−02
  *GSH oxidative stress*                                                                                           
  Methionine S-oxide              166.0534     18.3   6.29          3.40E−03      3.78          1.80E−02   3.26    2.00E−04
  Cystathione                     223.0749     21.8   2.13          5.00E−02      2.71          2.90E−02   1.81    1.80E−01
  GSH                             308.0912     16.3   0.05          9.50E−06      0.00          3.60E−01   0.01    3.30E−01
  GSH-cysteine                    427.0954     21.0   0.43          1.10E−02      0.41          2.60E−01   0.34    2.20E−01
  GSSG                            613.1594     20.5   0.52          7.10E−02      0.48          2.10E−01   0.26    1.70E−01
  *Methylation*                                                                                                    
  Methionine                      150.0584     13.9   2.52          2.00E−03      1.47          9.60E−02   1.70    2.90E−02
  S-adenosylmethionine            399.1448     24.6   2.25          5.20E−03      2.13          1.50E−02   2.263   1.70E−03
  *Purine metabolism*                                                                                              
  Guanine                         152.0544     13.9   2.41          4.10E−03      1.39          1.60E−01   1.50    6.20E−02
  Sepiapterin                     238.0936     10.3   0.03          2.90E−03      0.06          1.90E−02   0.246   1.90E−01
  Biopterin                       238.0938     13.2   0.63          1.20E−04      0.56          1.70E−02   0.311   2.20E−01
  Dihydrobiopterin                240.1093     13.9   0.25          6.50E−04      0.18          6.90E−04   0.263   2.00E−02
  Methyladenosine                 282.1185     19.4   2.70          2.80E−03      10.70         3.80E−03   1.02    8.80E−01
  Methylguanosine                 298.1146     11.1   0.43          3.90E−04      0.25          1.60E−03   0.552   5.20E−02
  *Misc. metabolites*                                                                                              
  Threonine                       120.0657     17.4   1.96          7.50E−03      2.43          1.10E−02   1.95    8.20E−03
  Asparagine                      133.0609     18.5   0.49          1.90E−02      0.45          8.30E−03   0.34    2.00E−03
  Glutamine                       147.0765     18.2   0.60          1.70E−02      0.55          7.60E−03   0.71    1.50E−04
  Histidine                       156.0769     22.6   0.63          1.00E−04      0.65          1.40E−02   0.61    4.20E−02
  Choline phosphate               184.0734     22.4   0.32          2.00E−03      0.30          9.60E−06   0.41    9.50E−06
  Dimethylarginine                203.1391     22.5   0.22          2.30E−02      ND            \-         0.61    3.10 E−02
  Cytidine                        244.093      17.8   1.66          1.80E−02      2.59          6.70E−03   0.485   1.40E−02
  Uridine                         245.077      10.8   1.17          2.90E−01      2.17          6.80E−02   0.674   2.60E−03
  Arginine phosphate              255.0853     22.8   0.56          7.00E−04      0.35          1.40E−04   0.326   3.20E−03
  Tyrosine phosphate              262.0475     20.7   1.06          3.50E−01      1.48          1.60−E02   0.264   3.60E−02
  Arginosuccinate                 291.1301     22.0   0.38          1.20E−03      0.45          1.60E−02   0.115   7.30E−03
  Riboflavin                      377.1454     9.5    3.23          1.10E−03      2.65          2.10E−02   2.842   1.40E−04
